For the first time, scientists put both medications head-to-head in a rigorous clinical trial and in May 2025, the results were published in the New England Journal of Medicine , the most respected medical journal in the world.[1] Here in Shreveport and across northwest Louisiana, where nearly 40% of adults are living with obesity, this study matters
16 This understanding must lead to definitive actions that provide equality to the treatment of obesity within a chronic disease framework, one in which PwO will not be discriminated against and will be equally supported
Galjaard S, et al
In diabetic mice, semaglutide alleviated anxiety- and depression-like behaviors and improved cognitive performance via modulation of the microbiota-gut-brain axis ( In summary, accumulating evidence supports the potential of GLP-1RAs in treating neurodegenerative and psychosocial disorders
* The FDA does not review or approve any compounded medications for safety or effectiveness
Avoid these common pitfalls: Injecting BAC water directly onto the lyophilized cake